{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:24:11Z","timestamp":1787109851796,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":6380,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.anpedi.2008.09.014","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T04:03:05Z","timestamp":1253764985000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Respuesta a la suspensi\u00f3n de azatioprina en pacientes con enfermedad de Crohn en terapia combinada con infliximab"],"prefix":"10.1016","volume":"70","author":[{"given":"J.","family":"Mart\u00edn De Carpi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Varea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2008.09.014_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.anpedi.2008.09.014_bib2","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2008.09.014_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anpedi.2008.09.014_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2036.2003.01411.x","article-title":"Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model","volume":"17","author":"Crandall","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.anpedi.2008.09.014_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anpedi.2008.09.014_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","article-title":"Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease","volume":"56","author":"Vermeire","year":"2007","journal-title":"Gut."},{"key":"10.1016\/j.anpedi.2008.09.014_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ibd.20412","article-title":"Effect of early immunomodulator use in moderate to severe pediatric Crohn disease","volume":"14","author":"Punaty","year":"2008","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.anpedi.2008.09.014_bib8","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.2000.03263.x","article-title":"Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease","volume":"95","author":"Kugathasan","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.anpedi.2008.09.014_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.dld.2003.12.014","article-title":"Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease","volume":"36","author":"Borrelli","year":"2004","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.anpedi.2008.09.014_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ibd.20069","article-title":"Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease","volume":"13","author":"Walters","year":"2007","journal-title":"Inflamm Bowel Dis."},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2008.09.014_bib11","first-page":"S42","article-title":"Top-down therapy with infliximab and azathioprine in newly diagnosed paediatric Crohn's disease","volume":"43","author":"Mart\u00edn de Carpi","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.anpedi.2008.09.014_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.anpedi.2008.09.014_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/gast.2000.16487","article-title":"Hodgkin's disease risk is increased in patients with ulcerative colitis","volume":"119","author":"Palli","year":"2000","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anpedi.2008.09.014_bib14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer."},{"key":"10.1016\/j.anpedi.2008.09.014_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ibd.20211","article-title":"Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?","volume":"13","author":"Jones","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.anpedi.2008.09.014_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T-cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.anpedi.2008.09.014_bib17","doi-asserted-by":"crossref","unstructured":"Shale M, Kanfer E, Panaccione, Ghosh S. Hepatosplenic T-cell lymphoma in inflammatory bowel disease. Gut 2008 [Epub ahead of print]; doi:10.1136\/gut.2008.163279.","DOI":"10.1136\/gut.2008.163279"},{"key":"10.1016\/j.anpedi.2008.09.014_bib18","unstructured":"US Food and Drug Administration center for drug evaluation and research website [citado 18 Ago 2008]. Disponible en: http:\/\/fda.gov\/cder\/aers\/anti-TNF."},{"key":"10.1016\/j.anpedi.2008.09.014_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MPG.0b013e31816a30b9","article-title":"Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab","volume":"47","author":"Frankolla","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.anpedi.2008.09.014_bib20","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","article-title":"Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial","volume":"134","author":"Van Assche","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anpedi.2008.09.014_bib21","doi-asserted-by":"crossref","unstructured":"Mart\u00edn de Carpi J, Vilar P, Varea V. Infliximab como terapia de rescate en colitis ulcerosa grave resistente al tratamiento corticoideo. An Pediatr (Barc). 2009 2008;69:351\u20134.","DOI":"10.1157\/13126560"},{"key":"10.1016\/j.anpedi.2008.09.014_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.MIB.0000158166.88238.ea","article-title":"Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium","volume":"11","author":"Jacobstein","year":"2005","journal-title":"Inflamm Bowel Dis."}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:26:50Z","timestamp":1787106410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403308000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1695403308000428"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.09.014","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respuesta a la suspensi\u00f3n de azatioprina en pacientes con enfermedad de Crohn en terapia combinada con infliximab","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}